
Goldman flags biopharma as China’s ageing winners, carmakers and hardware face headwinds
A demographic squeeze in China could tilt investment and demand toward pharmaceuticals, while autos and tech hardware get tougher.

Curating from trusted global sources…
Curated from trusted global sources, refined into briefing-grade analysis with executive summaries, insights, and bullet-point takeaways.

A demographic squeeze in China could tilt investment and demand toward pharmaceuticals, while autos and tech hardware get tougher.

A Shanghai robotics startup clears Europe’s medical gate while its clinical-grade AI model hits a top healthcare benchmark.

Walmart-backed Flipkart’s quick-commerce scale leap forces rivals and regulators to ask: who wins the next hour of demand?

Deal-by-deal, the Verge’s tested picks show which features you actually get under $300, $800, and $1,500+.

A 15-year-old plaintiff’s fight against three tech giants moves into court, testing how regulators frame harm claims.

The all-cash deal is a direct bet that the next marketing stack runs on millions of AI agents per user.

The experimental project, separate from Facebook and Instagram, aims to grab betting attention from prediction-market leaders.

Meta’s smart glasses launch with a fashion-first mindset, starting at $299, and Zuckerberg spells out the real engineering challenge.

An executive order demands quantum-safe encryption upgrades sooner, reshaping risk models, budgets, and vendor timelines across government and industry.

Familiar Faces will use non-biometric cues and auto-refresh images to cut mistaken smart home alerts.

The Superhuman team is snapping up GPTZero, and the move tightens the battle over who can reliably flag AI-generated text.

Federal officials want Meta, the major holdout, to let regulators run evaluations, weeks after Anthropic was told to pull a model.